FDA approves new treatment for diabetes-related vision loss

According to the American Diabetes Association, “Approximately 25% of Americans over the age of 60 years have diabetes, and aging of the U.S. population is widely acknowledged as one of the drivers of the diabetes epidemic.”

One of the more frightening consequences of diabetes is diabetic macular edema (DME), which can lead to acute vision loss. After three tries, the FDA has approved Iluvien, an implant that releases a low-dose corticosteroid over a three-year period to relieve pressure on the eye, and if all goes well, improve vision.

Alimera expects to begin selling Iluvien in the U.S. during the first quarter of 2015.

Obviously, if you’re considering having something injected into your eye, you want to have a thorough discussion with your doctor about side-effects. In the meantime, watching this demonstration video about Iluvien injection should get anyone who’s been warned about developing Type 2 diabetes to do whatever it takes to avoid the disease.

[youtube http://www.youtube.com/watch?v=u2lcTLDgacs#t=11]